Loading
Latest filing published 25 Jun 2021 for Genix Pharmaceuticals Corporation, €20k.
Jamie A. Lewin appears in our data through filings on Genix Pharmaceuticals Corporation shares, published by SEDI. Over a trading history stretching from 11 March 2019 to 25 June 2021, the count stands at 3 filings.
On the market, this insider has only sold: 1 sale, €20k in total. The rest of the record consists of 1 share grant. In 2021 alone, the filings show no purchases and 1 sale.
The newest entry dates from 25 June 2021: an open-market sale of €20k, in Genix Pharmaceuticals Corporation. Typically, a trade is published a median of 6 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations